PMA Stats & Data

Extremely narrow therapeutic index: the gap between a ‘common’ dose and life-threatening toxicity is small. PMA is frequently mis-sold as MDMA in pressed pills or powders, but it has slower onset (often >60 minutes) and less euphoria, prompting risky redosing that has been implicated in clusters of fatalities. Expect marked hyperthermia and hypertension risk; avoid hot environments, prolonged dancing, and strenuous activity. If effects are unexpectedly delayed or atypical for MDMA, do not redose and seek a cool, quiet space. Hydrate with small sips of isotonic fluids (~300 mL/hour) and avoid overhydration. Reagent testing: PMA typically shows no reaction with Marquis/Mecke; PMMA may show a blue Simon’s reaction without MDMA-like Marquis/Mecke changes. Absence of the expected MDMA reaction is a red flag—only lab drug checking (e.g., GC/MS) can confirm composition. Strongly avoid combinations with serotonergic agents (SSRIs, MAOIs, tramadol, dextromethorphan, triptans) and with other stimulants or MDMA, due to serotonin syndrome and hyperthermia risk. Seek emergency help for high temperature, confusion/agitation, severe headache, chest pain, or persistent vomiting. Given its poor safety profile and repeated association with deaths, routine recreational use is not advised.